Duality Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-58,915
| Closed | -$513K | – | 266 |
|
|
2024
Q1 | $513K | Sell |
58,915
-5,927
| -9% | -$51.6K | 0.05% | 452 |
|
|
2023
Q4 | $742K | Sell |
64,842
-8,966
| -12% | -$103K | 0.08% | 360 |
|
|
2023
Q3 | $711K | Buy |
73,808
+36,544
| +98% | +$352K | 0.09% | 359 |
|
|
2023
Q2 | $396K | Buy |
37,264
+3,453
| +10% | +$36.7K | 0.05% | 414 |
|
|
2023
Q1 | $356K | Sell |
33,811
-41,198
| -55% | -$433K | 0.04% | 465 |
|
|
2022
Q4 | $929K | Sell |
75,009
-101,239
| -57% | -$1.25M | 0.11% | 330 |
|
|
2022
Q3 | $1.83M | Buy |
176,248
+122,504
| +228% | +$1.27M | 0.2% | 202 |
|
|
2022
Q2 | $620K | Buy |
53,744
+37,834
| +238% | +$436K | 0.06% | 430 |
|
|
2022
Q1 | $200K | Buy |
+15,910
| New | +$200K | 0.02% | 603 |
|
|
2021
Q1 | – | Sell |
-142,346
| Closed | -$1.62M | – | 621 |
|
|
2020
Q4 | $1.62M | Buy |
142,346
+21,276
| +18% | +$242K | 0.12% | 258 |
|
|
2020
Q3 | $1.09M | Buy |
+121,070
| New | +$1.09M | 0.07% | 353 |
|